Selection of valve and procedural anticoagulant type may impact bleeding and vascular complications in transfemoral transcatheter aortic valve replacement (TAVR). We sought to compare outcomes by valve [balloon expandable (BE) or non-BE] and anticoagulant [bivalirudin vs. unfractionated heparin (UFH)] type from the BRAVO-3 trial.
Effect of valve design and anticoagulation strategy on 30-day clinical outcomes in transcatheter aortic valve replacement. results from the BRAVO 3 randomized trial / Linke, Axel; Chandrasekhar, Jaya; Sartori, Samantha; Lefevre, Thierry; van Belle, Eric; Schaefer, Ulrich; Tchetche, Didier; Sardella, Gennaro; Webb, John; Colombo, Antonio; Windecker, Stephan; Vogel, Birgit; Farhan, Serdar; Sorrentino, Sabato; Sharma, Madhav; Snyder, Clayton; Asgar, Anita; Dumonteil, Nicolas; Tamburino, Corrado; Hink, Ulrich; Violini, Roberto; Stella, Pieter; Bernstein, Debra; Deliargyris, Efthymios; Hengstenberg, Christian; Baber, Usman; Mehran, Roxana; Anthopoulos, Prodromos; Dangas, George. - In: CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS. - ISSN 1522-1946. - ELETTRONICO. - 90:5(2017), pp. 1016-1026. [10.1002/ccd.27154]
Effect of valve design and anticoagulation strategy on 30-day clinical outcomes in transcatheter aortic valve replacement. results from the BRAVO 3 randomized trial
SARDELLA, Gennaro;Violini, Roberto;
2017
Abstract
Selection of valve and procedural anticoagulant type may impact bleeding and vascular complications in transfemoral transcatheter aortic valve replacement (TAVR). We sought to compare outcomes by valve [balloon expandable (BE) or non-BE] and anticoagulant [bivalirudin vs. unfractionated heparin (UFH)] type from the BRAVO-3 trial.| File | Dimensione | Formato | |
|---|---|---|---|
|
Linke_Effect-Of-Valve_2017.pdf
solo gestori archivio
Tipologia:
Documento in Post-print (versione successiva alla peer review e accettata per la pubblicazione)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
1.02 MB
Formato
Adobe PDF
|
1.02 MB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
